Mark Fendrick

1 week ago | patientcareonline.com | Mark Fendrick |Grace Halsey

Mark Fendrick, MD, professor of internal medicine at the University of Michigan School of Medicine and professor of health management and policy at the university's school of public health, fully supports innovation when it comes to advancing public health.

1 week ago | patientcareonline.com | Mark Fendrick |Grace Halsey

Mark Fendrick, MD, professor of internal medicine at the University of Michigan School of Medicine and professor of health management and policy at the university's school of public health has been involved in research to develop, enhance, and refine noninvasive tests to assess for colorectal cancer (CRC) for many years. Most recently he participated in a study that compared the carbon footprints of stool DNA testing and colonoscopy.

1 month ago | patientcareonline.com | Mark Fendrick |Grace Halsey

Colonoscopy rates are going down, and stool testing is going up for colorectal cancer (CRC) screening, according to Mark Fendrick, MD, professor of internal medicine at the University of Michigan School of Medicine and professor of health management and policy at the university's school of public health.